A journal article's findings confirm that patients in Kentucky with private health insurance have better clinical outcomes than patients with other types of insurance.
In reports of industry-funded studies that compared the ocular hypotensive efficacy of topical prostaglandins, conclusions in the article abstracts differed from the results of the main outcome measure 62 percent of the time.